Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy

References

• Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69:491–497.
   PubMed Web of Science ®Google Scholar
• O’Brian K, Luo S, Ganti A, et al. Short- and long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy. Leuk Lymphoma. 2016;57:313–319.
   PubMed Web of Science ®Google Scholar
• Han X, Stevens J, Bradshaw PT. Body mass index, weight change, and survival in non-Hodgkin lymphoma patients in Connecticut women. Nutr Cancer. 2013;65:43–50.
   PubMed Web of Science ®Google Scholar
• Chin Y, Liu J, Tai J, et al. The significance of body weight change in non-Hodgkins lymphoma. Anticancer Res. 1999;19:5607–5610.
   PubMed Web of Science ®Google Scholar
• Stanisavljevic NS, Marisavljevic DZ. Weight and body composition changes during R-CHOP chemotherapy in patients with non-Hodgkin’s lymphoma and their impact on dose intensity and toxicity. J Buon. 2010;15:290–296.
   PubMed Web of Science ®Google Scholar
• Lynce F, Pehlivanova M, Catlett J, et al. Obesity in adult lymphoma survivors. Leuk Lymphoma. 2012;53:569–574.
   PubMed Web of Science ®Google Scholar
• Thivat E, Thérondel S, Lapirot O, et al. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer. 2010;10:648.
   PubMed Web of Science ®Google Scholar
• Kroenke CH, Chen WY, Rosner B, et al. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23:1370–1378.
   PubMed Web of Science ®Google Scholar
• Topkan E, Parlak C, Selek U. Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients. Int J Radiat Oncol. 2013;87:697–704.
   PubMed Web of Science ®Google Scholar
• Hess LM, Barakat R, Tian C, et al. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2007;107:260–265.
   PubMed Web of Science ®Google Scholar
• Adams K, Schatzkin A, Harris T, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–778.
   PubMed Web of Science ®Google Scholar
• Kolotkin R, Meter K, Williams G. Quality of life and obesity. Obes Rev. 2001;2:219–229.
   PubMedGoogle Scholar
• Wannamethee S, Shaper A, Walker M. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health. 2005;59:134–139.
   PubMed Web of Science ®Google Scholar
• Kopelman P. Obesity as a medical problem. Nature. 2000;404:635–643.
   PubMed Web of Science ®Google Scholar
• Willett W, Manson J, Stampfer M, et al. Weight, weight change, and coronary heart disease in women. J Am Med Assoc. 1995;273:461–467.
   PubMed Web of Science ®Google Scholar
• Liu Q, Fayad L, Cabanillas F, et al. Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center. J Clin Oncol. 2006;24:1582–1589.
   PubMed Web of Science ®Google Scholar
• Swenson WT, Wooldridge JE, Lynch CF, et al. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol. 2005;23:5019–5026.
   PubMed Web of Science ®Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695–708.
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
   Google Scholar
• Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases: differing perspectives. J Clin Epidemiol. 1993;46:1075–1079.
   PubMed Web of Science ®Google Scholar
• Savas LS, del Junco DJ, Bastian LA, et al. Mortality ascertainment of women veterans: a comparison of sources of vital status information, 1979–2002. Med Care. 2009;47:125–128.
   PubMed Web of Science ®Google Scholar
• Sohn M-W, Arnold N, Maynard C, et al. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006;4:2.
   PubMedGoogle Scholar
• Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes. 2011;4:363–371.
   PubMed Web of Science ®Google Scholar
• Buske C, Hoster E, Dreyling M, et al. The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vinc. Blood. 2006;108:1504–1508.
   PubMed Web of Science ®Google Scholar
• Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–1265.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392–2404.
   PubMed Web of Science ®Google Scholar
• Wang Y, Beydoun MA. The obesity epidemic in the United States – gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28.
   PubMed Web of Science ®Google Scholar
• Trotman J, Fournier M, Lamy T, et al. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol. 2011;29:3194–3200.
   PubMed Web of Science ®Google Scholar